Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 73.40 ▲ 1.01 (1.40%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AbbVie Inc | ABBV | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.72 | 1.0% | 72.39 | 73.00 | 71.91 | 71.91 | 71.67 | 19:59:46 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 77,552 | 13,169,676 | $ 72.17 | $ 950,453,370 | 8,214,763 | 62.66 - 96.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:33 | 3 | $ 73.37 | USD |
AbbVie Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 107.03B | 1.48B | $ 5.69B | 3.68 | 25.00 | 1.48B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 52.54M | $ 3.59 | 4.96% | 10/11/19 | - | - |
AbbVie News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABBV Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 71.15 | 73 | 70.36 | 71.2671 | 6M | 1.24 | 1.74% |
| 1 Month | 67.28 | 73 | 64.44 | 68.0373 | 8M | 5.11 | 7.60% |
| 3 Months | 70.58 | 75 | 62.66 | 68.3183 | 10M | 1.81 | 2.56% |
| 6 Months | 80.72 | 84.73 | 62.66 | 71.7456 | 8M | -8.33 | -10.32% |
| 1 Year | 91.43 | 96.6 | 62.66 | 77.0534 | 7M | -19.04 | -20.82% |
| 3 Years | 63.36 | 125.86 | 55.0623 | 80.9050 | 6M | 9.03 | 14.25% |
| 5 Years | 59.23 | 125.86 | 45.45 | 71.0995 | 7M | 13.16 | 22.22% |
AbbVie Description
| AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. |
